<https://rdf.molmedb.upol.cz/reference/ref3829> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM492156>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2013.03.081"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM492157>,
		<https://identifiers.org/molmedb/MM493144>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/pmid> "23591112"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Gao Z, Hurst WJ, Guillot E, Czechtizky W, Lukasczyk U, Nagorny R, Pruniaux MP, Schwink L, Sanchez JA, Stengelin S, Tang L, Winkler I, Hendrix JA, George PG.: Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II). Bioorg Med Chem Lett, Volume 23 (11), 2013"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21>,
		<https://identifiers.org/molmedb/MM493142>,
		<https://identifiers.org/molmedb/MM493143> .
<https://rdf.molmedb.upol.cz/interaction/int1029851> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3829> .
<https://rdf.molmedb.upol.cz/interaction/int1029853> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3829> .
<https://rdf.molmedb.upol.cz/interaction/int1029852> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3829> .
<https://rdf.molmedb.upol.cz/interaction/int1027182> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3829> .
<https://rdf.molmedb.upol.cz/interaction/int1027181> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3829> .